Coverage of human papillomavirus vaccination during the first year of its introduction in Spain.

نویسندگان

  • A Limia
  • I Pachón
چکیده

The decision to introduce human papillomavirus (HPV) vaccination into the national immunisation programme in Spain was made in October 2007, recommending vaccination of girls aged between 11 and 14 years with three doses of HPV vaccine. All 19 regions of the country (17 Autonomous Communities and two Autonomous Cities) introduced HPV vaccination gradually into their immunisation programmes between November 2007 and the last school term of 2008. Eight regions administered the vaccine in healthcare centres and 11 in schools. In the first year of the introduction of HPV vaccination, coverage of the first and third doses was assessed, to determine the proportion of girls who did not complete the vaccination. On the basis of the available data, the Ministry of Health estimated that coverage for the first dose was 87.2% (range: 73.9–98.9%; 95% CI: 71.8 to 100) and 77.3% (range: 62.2–97.4%; 95% CI: 57.9 to 96.7) for the third dose. Higher uptake was observed when the vaccination was carried out in schools compared with healthcare centres, but the difference was not statistically significant. Negative messages in the media during implementation of the HPV vaccination programme may have had some influence on the attitudes of adolescent girls and/or their parents towards HPV vaccination and may be partly responsible for the observed vaccination dropout rate.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Interim estimates of male human papillomavirus vaccination coverage in the school-based program in Australia.

In February 2013, following the successful establishment of the National Human Papillomavirus (HPV) Vaccination Program for females in Australia in 2007,1,2 the program was extended to males. This followed a recommendation by the Pharmaceutical Benefits Advisory Committee that extension of the quadrivalent HPV vaccine program to males would be acceptably cost-effective compared with female only...

متن کامل

Knowledge and attitude of interns of Yazd Shahid Sadoughi University of Medical Sciences regarding vaccination of Human Papillomavirus (HPV): 2018

Introduction: Regarding the level of awareness and attitudes in different societies, it seems that the way of informing the target group about HPV vaccination is important in the health care sector, especially physicians. Therefore, we decided to investigate the level of knowledge and attitude of the interns of Shahid Sadoughi University of Medical Sciences in Yazd regarding HPV vaccination in ...

متن کامل

ارزیابی اثر برنامه واکسیناسیون دام ها علیه تب مالت بر میزان بروز انسانی آن در استان همدان از سال 1381 لغایت 1387

Introduction & Objective: Brucellosis is an important zoonosis considered a serious hazard to public health . Human brucellosis is caused by one of the four species of the brucella genus: B. melitensis is principally found in goats and sheep, B. abortus in cattle, B. suis in swine and B. canis in dogs. Vaccination of young animals, is a strategy to decrease the incidence rate of brucellosis i...

متن کامل

[Acceptability of human papillomavirus vaccine in mothers from Valencia (Spain)].

INTRODUCTION In October 2008, Valencian Community started its human papillomavirus (HPV) vaccination schedules for 14 year-old girls. The aim of this study is to assess knowledge about HPV infection and its vaccine among the mothers of these girls, and to identify factors associated with the willingness to vaccinate their daughters. MATERIAL AND METHODS Cross-sectional study by means of a que...

متن کامل

Achieving high coverage in Rwanda's national human papillomavirus vaccination programme.

PROBLEM Virtually all women who have cervical cancer are infected with the human papillomavirus (HPV). Of the 275,000 women who die from cervical cancer every year, 88% live in developing countries. Two vaccines against the HPV have been approved. However, vaccine implementation in low-income countries tends to lag behind implementation in high-income countries by 15 to 20 years. APPROACH In ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

دوره 16 21  شماره 

صفحات  -

تاریخ انتشار 2011